You are here

P&T News

January 22

Approximately 40% of Patients With BRAF-Mutated Biliary Tract Cancer Respond Well

January 17

Health Outcomes Have No Improvement
Adjunctive Therapy is First Generic Version of Sabril for Focal Seizures
Targeted Antibody for FGR3-Positive Mutation
Method Could Lead to Manufacturing Corneas for Transplants
iPSC Therapy Designed to Salvage Eye, Prevent Vision Loss

January 15

First and Only Second-Generation TKI for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Potential Life-Saving Device Can be Implanted in 2-LB Babies
New Therapy for Patients With HCC Who Previously Received Nexavar
Aggressive Disease Represents Around 6% of All New Cases of NHL

January 10

New Therapy Could Prevent Painful, Unpredictable Pain Crises
Study Reveals Having Any Cancer Type Increases Risk by 40 Percent
Relief for Patients With Life-Threatening Blood-Clotting Disorder

January 8

Data from Phase 1 Study Expected by Summer of 2019
Less Burdensome Therapy for Patients With Paroxysmal Nocturnal Hemoglobinuria
Injecting Corrupted Drug Could Cause Phlebitis, Pulmonary Embolic Events
Treatment for 150 Million Cases of UTIs Costs $6 Billion/Year

December 18

Argos Device Could Reduce Cost and Amount of Work for CO Monitoring
Drug Expected to Launch in 2019, Offering Hope to 35 Million U.S. Adults

Pages